FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2935355093> ?p ?o ?g. }

• W2935355093 endingPage "136.e9" @default.
• W2935355093 startingPage "136.e1" @default.
• W2935355093 abstract "Background Communicating healthcare costs to patients is an important component of delivering high-quality value-based care, yet cost data are lacking. This is especially relevant for ovarian cancer, where no clinical consensus on optimal first-line treatment exists. Objective The objective of this study was to generate cost estimates of different primary management strategies in ovarian cancer. Study Design All women who underwent treatment for ovarian cancer from 2006–2015 were identified from the MarketScan database (n=12,761) in this observational cohort study. Total and out-of-pocket costs were calculated with the use of all claims within 8 months from initial treatment and normalized to 2017 US dollars. The generalized linear model method was used to assess cost by strategy. Results Among patients who underwent neoadjuvant chemotherapy and those who underwent primary debulking, mean adjusted total costs were $113,660 and $107,153 (P<.001) and mean out-of-pocket costs were $2519 and $2977 (P<.001), respectively. Total costs for patients who had intravenous standard, intravenous dose-dense, and intraperitoneal/intravenous chemotherapy were $105,047, $115,099, and $121,761 (P<.001); and out-of-pocket costs were $2838, $3405, and $2888 (P<.001), respectively. Total costs for regimens that included bevacizumab were higher than those without it ($171,468 vs $104,482; P<.001); out-of-pocket costs were $3127 vs $2898 (P<.001). Among patients who did not receive bevacizumab, 25% paid ≥$3875, and 10% paid ≥$6265. For patients who received bevacizumab, 25% paid ≥$4480, and 10% paid ≥$6635. Among patients enrolled in high-deductible health plans, median out-of-pocket costs were $4196, with 25% paying ≥$6680 and 10% paying ≥$9751. Conclusion Costs vary across different treatment strategies, and patients bear a significant out-of-pocket burden, especially those enrolled in high-deductible health plans. Communicating healthcare costs to patients is an important component of delivering high-quality value-based care, yet cost data are lacking. This is especially relevant for ovarian cancer, where no clinical consensus on optimal first-line treatment exists. The objective of this study was to generate cost estimates of different primary management strategies in ovarian cancer. All women who underwent treatment for ovarian cancer from 2006–2015 were identified from the MarketScan database (n=12,761) in this observational cohort study. Total and out-of-pocket costs were calculated with the use of all claims within 8 months from initial treatment and normalized to 2017 US dollars. The generalized linear model method was used to assess cost by strategy. Among patients who underwent neoadjuvant chemotherapy and those who underwent primary debulking, mean adjusted total costs were $113,660 and $107,153 (P<.001) and mean out-of-pocket costs were $2519 and $2977 (P<.001), respectively. Total costs for patients who had intravenous standard, intravenous dose-dense, and intraperitoneal/intravenous chemotherapy were $105,047, $115,099, and $121,761 (P<.001); and out-of-pocket costs were $2838, $3405, and $2888 (P<.001), respectively. Total costs for regimens that included bevacizumab were higher than those without it ($171,468 vs $104,482; P<.001); out-of-pocket costs were $3127 vs $2898 (P<.001). Among patients who did not receive bevacizumab, 25% paid ≥$3875, and 10% paid ≥$6265. For patients who received bevacizumab, 25% paid ≥$4480, and 10% paid ≥$6635. Among patients enrolled in high-deductible health plans, median out-of-pocket costs were $4196, with 25% paying ≥$6680 and 10% paying ≥$9751. Costs vary across different treatment strategies, and patients bear a significant out-of-pocket burden, especially those enrolled in high-deductible health plans." @default.
• W2935355093 created "2019-04-11" @default.
• W2935355093 creator A5000098403 @default.
• W2935355093 creator A5027028437 @default.
• W2935355093 creator A5034465643 @default.
• W2935355093 creator A5038767467 @default.
• W2935355093 creator A5046014508 @default.
• W2935355093 creator A5055471313 @default.
• W2935355093 creator A5078692182 @default.
• W2935355093 creator A5088938634 @default.
• W2935355093 creator A5090232818 @default.
• W2935355093 date "2019-08-01" @default.
• W2935355093 modified "2023-10-17" @default.
• W2935355093 title "Total and out-of-pocket costs of different primary management strategies in ovarian cancer" @default.
• W2935355093 cites W2035227308 @default.
• W2935355093 cites W2050056063 @default.
• W2935355093 cites W2085515680 @default.
• W2935355093 cites W2099354636 @default.
• W2935355093 cites W2105556681 @default.
• W2935355093 cites W2106767659 @default.
• W2935355093 cites W2113122060 @default.
• W2935355093 cites W2130806638 @default.
• W2935355093 cites W2135947389 @default.
• W2935355093 cites W2136919572 @default.
• W2935355093 cites W2154175915 @default.
• W2935355093 cites W2266198524 @default.
• W2935355093 cites W2292373964 @default.
• W2935355093 cites W2340132019 @default.
• W2935355093 cites W2350476508 @default.
• W2935355093 cites W2749628778 @default.
• W2935355093 cites W2770173806 @default.
• W2935355093 cites W4212771103 @default.
• W2935355093 doi "https://doi.org/10.1016/j.ajog.2019.04.005" @default.
• W2935355093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7392324" @default.
• W2935355093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30965052" @default.
• W2935355093 hasPublicationYear "2019" @default.
• W2935355093 type Work @default.
• W2935355093 sameAs 2935355093 @default.
• W2935355093 citedByCount "23" @default.
• W2935355093 countsByYear W29353550932019 @default.
• W2935355093 countsByYear W29353550932020 @default.
• W2935355093 countsByYear W29353550932021 @default.
• W2935355093 countsByYear W29353550932022 @default.
• W2935355093 countsByYear W29353550932023 @default.
• W2935355093 crossrefType "journal-article" @default.
• W2935355093 hasAuthorship W2935355093A5000098403 @default.
• W2935355093 hasAuthorship W2935355093A5027028437 @default.
• W2935355093 hasAuthorship W2935355093A5034465643 @default.
• W2935355093 hasAuthorship W2935355093A5038767467 @default.
• W2935355093 hasAuthorship W2935355093A5046014508 @default.
• W2935355093 hasAuthorship W2935355093A5055471313 @default.
• W2935355093 hasAuthorship W2935355093A5078692182 @default.
• W2935355093 hasAuthorship W2935355093A5088938634 @default.
• W2935355093 hasAuthorship W2935355093A5090232818 @default.
• W2935355093 hasBestOaLocation W29353550931 @default.
• W2935355093 hasConcept C121608353 @default.
• W2935355093 hasConcept C126322002 @default.
• W2935355093 hasConcept C141071460 @default.
• W2935355093 hasConcept C143998085 @default.
• W2935355093 hasConcept C162324750 @default.
• W2935355093 hasConcept C175444787 @default.
• W2935355093 hasConcept C182299520 @default.
• W2935355093 hasConcept C194828623 @default.
• W2935355093 hasConcept C23131810 @default.
• W2935355093 hasConcept C2776694085 @default.
• W2935355093 hasConcept C2777802072 @default.
• W2935355093 hasConcept C2780427987 @default.
• W2935355093 hasConcept C2781100745 @default.
• W2935355093 hasConcept C29456083 @default.
• W2935355093 hasConcept C71924100 @default.
• W2935355093 hasConceptScore W2935355093C121608353 @default.
• W2935355093 hasConceptScore W2935355093C126322002 @default.
• W2935355093 hasConceptScore W2935355093C141071460 @default.
• W2935355093 hasConceptScore W2935355093C143998085 @default.
• W2935355093 hasConceptScore W2935355093C162324750 @default.
• W2935355093 hasConceptScore W2935355093C175444787 @default.
• W2935355093 hasConceptScore W2935355093C182299520 @default.
• W2935355093 hasConceptScore W2935355093C194828623 @default.
• W2935355093 hasConceptScore W2935355093C23131810 @default.
• W2935355093 hasConceptScore W2935355093C2776694085 @default.
• W2935355093 hasConceptScore W2935355093C2777802072 @default.
• W2935355093 hasConceptScore W2935355093C2780427987 @default.
• W2935355093 hasConceptScore W2935355093C2781100745 @default.
• W2935355093 hasConceptScore W2935355093C29456083 @default.
• W2935355093 hasConceptScore W2935355093C71924100 @default.
• W2935355093 hasFunder F4320307770 @default.
• W2935355093 hasFunder F4320308129 @default.
• W2935355093 hasFunder F4320309682 @default.
• W2935355093 hasFunder F4320315087 @default.
• W2935355093 hasFunder F4320332161 @default.
• W2935355093 hasFunder F4320337351 @default.
• W2935355093 hasIssue "2" @default.
• W2935355093 hasLocation W29353550931 @default.
• W2935355093 hasLocation W29353550932 @default.
• W2935355093 hasLocation W29353550933 @default.
• W2935355093 hasOpenAccess W2935355093 @default.
• W2935355093 hasPrimaryLocation W29353550931 @default.
• W2935355093 hasRelatedWork W2065800215 @default.

• next